This inventor holds 1 USPTO granted patent. Top assignee: Cincinnati Children's Hospital Medical Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Wujuan Zhang: Innovator in Genomic Instability Research
Introduction
Wujuan Zhang is a prominent inventor based in Cincinnati, Ohio. He has made significant contributions to the field of genomic instability, particularly in relation to Fanconi anemia. His work has implications for both therapeutic and diagnostic applications.
Latest Patents
Wujuan Zhang holds a patent titled "Genomic instability markers in Fanconi anemia." This patent focuses on markers for genomic instability in Fanconi Anemia (FA) and other pathologies. It highlights the alteration of glycosphingolipid metabolism in FA deficient squamous cell carcinoma (SCC) cells. The findings suggest that ganglioside metabolism plays a crucial role in the susceptibility of FA patients to SCC progression. He has 1 patent to his name.
Career Highlights
Wujuan Zhang is affiliated with Cincinnati Children's Hospital Medical Center, where he conducts his research. His work is instrumental in advancing the understanding of genomic instability and its implications for various diseases.
Collaborations
Some of his notable coworkers include Lindsey Romick-Rosendale and Xueheng Zhao. Their collaborative efforts contribute to the ongoing research in the field of genomic instability.
Conclusion
Wujuan Zhang's innovative research in genomic instability marks him as a key figure in the scientific community. His contributions are paving the way for advancements in the understanding and treatment of Fanconi anemia and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile